Walleye Trading’s Apexigen, Inc. Common Stock APGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,268
Closed -$165K 5701
2022
Q2
$165K Hold
16,268
﹤0.01% 3833
2022
Q1
$164K Hold
16,268
﹤0.01% 3955
2021
Q4
$163K Buy
+16,268
New +$162K ﹤0.01% 4060

Other funds holding APGN

Walleye Trading's APGN Position: Q3 2022 in Review

Walleye Trading sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 16,268 shares — an estimated $165K sold.

Walleye Trading first reported a position in APGN in Q4 2021 and held it in 3 quarters. The position peaked at $165K in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

  • Walleye Trading reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 16,268 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $165K.
  • Walleye Trading first reported a position in Apexigen, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Walleye Trading's Apexigen, Inc. Common Stock position peaked at $165K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.